Literature DB >> 34591810

Diagnosis and Acute Management of COVID-19 and Multisystem Inflammatory Syndrome in Children.

Teresa B Kortz, Emilia Connolly, C Lee Cohen, Rebecca E Cook, Jennifer A Jonas1, Michael S Lipnick, Niranjan Kissoon.   

Abstract

ABSTRACT: Most children with coronavirus disease 2019 (COVID-19) infection are asymptomatic or have mild disease. About 5% of infected children will develop severe or critical disease. Rapid identification and treatment are essential for children who are critically ill with signs and symptoms of respiratory failure, septic shock, and multisystem inflammatory syndrome in children. This article is intended for pediatricians, pediatric emergency physicians, and individuals involved in the emergency care of children. It reviews the current epidemiology of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in children, summarizes key aspects of clinical assessment including identification of high-risk patients and manifestations of severe disease, and provides an overview of COVID-19 management in the emergency department based on clinical severity.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 34591810      PMCID: PMC8855974          DOI: 10.1097/PEC.0000000000002538

Source DB:  PubMed          Journal:  Pediatr Emerg Care        ISSN: 0749-5161            Impact factor:   1.602


  49 in total

1.  New spectrum of COVID-19 manifestations in children: Kawasaki-like syndrome and hyperinflammatory response.

Authors:  Sirada Panupattanapong; Elizabeth B Brooks
Journal:  Cleve Clin J Med       Date:  2020-12-31       Impact factor: 2.321

2.  National Trends of Cases of COVID-19 in Children Based on US State Health Department Data.

Authors:  Blake Sisk; William Cull; J Mitchell Harris; Alexandra Rothenburger; Lynn Olson
Journal:  Pediatrics       Date:  2020-09-29       Impact factor: 7.124

3.  Severe neutropenia in infants with severe acute respiratory syndrome caused by the novel coronavirus 2019 infection.

Authors:  Elisabetta Venturini; Giordano Palmas; Carlotta Montagnani; Elena Chiappini; Francesco Citera; Valeria Astorino; Sandra Trapani; Luisa Galli
Journal:  J Pediatr       Date:  2020-05-19       Impact factor: 4.406

4.  Lung Ultrasound in Children With COVID-19.

Authors:  Marco Denina; Carlo Scolfaro; Erika Silvestro; Giulia Pruccoli; Federica Mignone; Marisa Zoppo; Ugo Ramenghi; Silvia Garazzino
Journal:  Pediatrics       Date:  2020-04-21       Impact factor: 7.124

5.  Hemodynamic support in fluid-refractory pediatric septic shock.

Authors:  G Ceneviva; J A Paschall; F Maffei; J A Carcillo
Journal:  Pediatrics       Date:  1998-08       Impact factor: 7.124

6.  Prevalence of SARS-CoV-2 Infection in Children Without Symptoms of Coronavirus Disease 2019.

Authors:  Ana Marija Sola; Abel P David; Kristina W Rosbe; Atsuko Baba; Lynn Ramirez-Avila; Dylan K Chan
Journal:  JAMA Pediatr       Date:  2021-02-01       Impact factor: 16.193

7.  Clinical Outcomes of Coronavirus Disease 2019 With Evidence-based Supportive Care.

Authors:  Derek T Larson; John H Sherner; Kia M Gallagher; Cynthia L Judy; Madison B Paul; Alexandra M Mahoney; Peter J Weina
Journal:  Clin Infect Dis       Date:  2022-01-07       Impact factor: 9.079

8.  SARS-COV-2 infection in children and newborns: a systematic review.

Authors:  Ilaria Liguoro; Chiara Pilotto; Margherita Bonanni; Maria Elena Ferrari; Anna Pusiol; Agostino Nocerino; Enrico Vidal; Paola Cogo
Journal:  Eur J Pediatr       Date:  2020-05-18       Impact factor: 3.860

9.  Status epilepticus as a first presentation of COVID-19 infection in a 3 years old boy; Case report and review the literature.

Authors:  Amir Saeed; Eslam Shorafa
Journal:  IDCases       Date:  2020-09-03

10.  Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2.

Authors:  Elizabeth Whittaker; Alasdair Bamford; Julia Kenny; Myrsini Kaforou; Christine E Jones; Priyen Shah; Padmanabhan Ramnarayan; Alain Fraisse; Owen Miller; Patrick Davies; Filip Kucera; Joe Brierley; Marilyn McDougall; Michael Carter; Adriana Tremoulet; Chisato Shimizu; Jethro Herberg; Jane C Burns; Hermione Lyall; Michael Levin
Journal:  JAMA       Date:  2020-07-21       Impact factor: 157.335

View more
  1 in total

Review 1.  Ofeleein i mi Vlaptin-Volume II: Immunity Following Infection or mRNA Vaccination, Drug Therapies and Non-Pharmacological Management at Post-Two Years SARS-CoV-2 Pandemic.

Authors:  Jannis Kountouras; Dimitra Gialamprinou; Georgios Kotronis; Apostolis Papaefthymiou; Eleftheria Economidou; Elpidoforos S Soteriades; Elisabeth Vardaka; Dimitrios Chatzopoulos; Maria Tzitiridou-Chatzopoulou; Dimitrios David Papazoglou; Michael Doulberis
Journal:  Medicina (Kaunas)       Date:  2022-02-17       Impact factor: 2.430

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.